The importance of the IL-1 family of cytokines in nanoimmunosafety and nanotoxicology

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022 Nov;14(6):e1850. doi: 10.1002/wnan.1850.

Abstract

Engineered nanomaterials (ENMs) to which humans are exposed intentionally as nanomedicines or unintentionally as invaders, may elicit unforeseen immune reactions. An uncontrollable ENM-induced immune response poses a potential danger to the human body. During an immunological reaction, interleukin (IL)-1 family cytokines, which play key roles under both physiological and pathological conditions, can be secreted by various types of cells into the surrounding environment to induce a series of defensive reactions. However, the crucial roles played by IL-1 family cytokines in ENM-induced immunological responses have not attracted enough attention from researchers to date. In this review, ENM-mediated inflammatory responses and immunotoxicity are discussed, with the main focus directed to IL-1 family cytokines, including IL-1α, IL-1β, IL-1Ra, IL-18, IL-33, IL-36, IL-37, and IL-38. The potential molecular mechanisms of IL-1 family cytokine activity triggered by ENMs, particularly the activation of IL-1α, IL-1β, IL-18, and IL-33, are also reviewed. The understanding of IL-1 family cytokines on nanoimmunosafety provides a fundamental basis for designing safe ENMs that can potentially be used for nanomedicine. This article is categorized under: Toxicology and Regulatory Issues in Nanomedicine > Toxicology of Nanomaterials.

Keywords: immunotoxicity; inflammasome; inflammation; interleukin-1 family; nanosafety.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Transport
  • Humans
  • Interleukin-18*
  • Interleukin-33
  • Interleukins
  • Nanomedicine
  • Nanostructures* / toxicity

Substances

  • Interleukin-18
  • Interleukin-33
  • IL-38 protein, human
  • Interleukins